[HTML][HTML] Prevention of herpes zoster: a focus on the effectiveness and safety of herpes zoster vaccines

Y Marra, F Lalji - Viruses, 2022 - mdpi.com
Infection with varicella zoster virus typically occurs in children and it can cause primary
varicella infection or “chickenpox”, or it can reactivate later in life and cause herpes zoster or …

Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy

G Reynolds, VG Hall, BW Teh - Transplant Infectious Disease, 2023 - Wiley Online Library
Revaccination after receipt of a hematopoietic cell transplant (HCT) or cellular therapies is a
pillar of patient supportive care, with the potential to reduce morbidity and mortality linked to …

[HTML][HTML] Corticosteroids contribute to serious adverse events following live attenuated varicella vaccination and live attenuated zoster vaccination

NB Price, C Grose - Vaccines, 2021 - mdpi.com
Corticosteroids, when given in high dosages, have long been recognized as a risk factor for
severe infection with wild-type varicella-zoster virus in both children and adults. The goal of …

[HTML][HTML] N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory …

AR Hoover, S More, K Liu, CL West, TI Valerio… - Acta Biomaterialia, 2024 - Elsevier
Mucosal vaccinations for respiratory pathogens provide effective protection as they stimulate
localized cellular and humoral immunities at the site of infection. Currently, the major …

Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia's spontaneous vaccine …

J Li-Kim-Moy, A Phillips, A Morgan, C Glover… - BMJ open, 2023 - bmjopen.bmj.com
Objectives To examine the reported incidence and features of disseminated varicella zoster
virus (VZV) infection following live attenuated herpes zoster vaccine live (ZVL: Zostavax …

Recurrent varicella following SARS‐CoV‐2 vaccination with BNT162b2

K Nanova, A Zlotogorski, Y Ramot - International Journal of …, 2021 - ncbi.nlm.nih.gov
Dear Editor, Recurrent varicella zoster virus (VZV) infection is an uncommon phenomenon,
especially in immunocompetent patients, and has only sparsely been reported in the past …

Varicella caused by airborne transmission of a localised herpes zoster infection in a family

Y Hatsushika, I Nii, T Taniguchi - BMJ Case Reports CP, 2021 - casereports.bmj.com
Localised herpes zoster infections spread by direct contact with active skin lesion, but
airborne transmission is rare. We report a case of varicella from airborne transmission of a …

Disseminated herpes zoster in an immune‐competent patient after SARS‐CoV‐2 vaccine (BNT162b2 Comirnaty, Pfizer).

C Zengarini, C Misciali, T Ferrari… - Journal of the …, 2022 - search.ebscohost.com
Causes of its apparition may be found in constitutive or temporal alteration, especially in
healthy hosts, in cellular immunity. 2 Here, we present a case of a healthy patient who …

General practitioner knowledge gaps regarding live attenuated zoster vaccination of immunocompromised individuals: An ongoing concern?

A Dey, H Rashid, K Sharma, A Phillips… - Australian Journal of …, 2022 - search.informit.org
Background and objective: Live attenuated herpes zoster vaccine (Zostavax [CSL/Merck])
was included on the Australian National Immunisation Program from 1 November 2016 for …

A novel biopolymer for mucosal adjuvant against respiratory pathogens

AR Hoover, S More, K Liu, CL West, TI Valerio… - bioRxiv, 2022 - biorxiv.org
Mucosal vaccinations for respiratory pathogens provide effective protection as they stimulate
localized cellular and humoral immunities at the site of infection. Currently, the major …